Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.

Biotechnology

Ventyx Biosciences

Raju Mohan

Andria Tsang Hambly

Nada Mitic

Kye Gilder

Suman Bhattacharya

Snehal Naik

Emily Samec

Chohee Yun, MD

John Nuss

Chris Krueger

Martin D. Auster

Ventyx Biosciences' Founding Team includes Raju Mohan.

Founding Team

Board of Directors

CEO and Executive Team

Leadership Team

Founding Team

About

Team members

Other teams at Ventyx Biosciences

Board of Directors

CEO and Executive Team

Leadership Team